Supplementary Table 2 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Response and response duration in participants whose tumors were non–MSI-H
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Gastric Cancer Management and Outcomes
Colorectal Cancer Treatments and Studies
Publication details
- Publication date
- 26 March 2026
- Language
- EN